Boyce Elisabeth Amanda
Transaction: 12/01/2028
OTHER
Change
+295,985
Price
Not reported
Filing
04/16/2026
Type
OTHER
Immutep Limited
IMMP • Biotechnology
$0.36
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$53.78M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 164.5%Manageable debt level · 0.02Healthy liquidity · 5.69Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:14 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.36
Change0.00%
Shares Out147.37M
Market Cap$53.78M
52W Range0.29 - 3.53
Beta2.25
P/E-1.13
P/S6.22
P/B1.44
P/FCF-1.63
EV/Sales1.46
EV/EBITDA-0.26
Price$0.36
Change0.00%
Shares Out147.37M
Market Cap$53.78M
52W Range0.29 - 3.53
Beta2.25
P/E-1.13
P/S6.22
P/B1.44
P/FCF-1.63
EV/Sales1.46
EV/EBITDA-0.26
EV/FCF-0.38
Earnings Yield-87.55%
FCF Yield-61.33%
Dividend Yield0.00%
Gross Margin83.01%
Oper. Margin-5.76%
Profit Margin-5.45%
Debt/Eq0.02
Current Ratio5.69
Quick Ratio5.69
Target$4.25
Target Upside1064.70%
Target Median$4.25
Target Range3.50 - 5.00
Volume132.67K
Avg Volume627.13K
EPS Surprise-0.02
Investment DNA
How strong this company looks for long-term investors
52
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
71/100
Why this score▼
Positive revenue growth · 164.5%Manageable debt level · 0.02Healthy liquidity · 5.69Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
75/100
Bullish
Bullish
2
Hold
2
Bearish
0
Price Target
2026-09-04
Low
$3.50
Mean
$4.25
Median
$4.25
High
$5.00
Insider Transactions
Recent executive and insider activity
Boyce Elisabeth Amanda
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/16/2026
Type
OTHER
Miller Deanne Diem
Transaction: 12/01/2028
OTHER
Change
+600,000
Price
Not reported
Filing
04/13/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Boyce Elisabeth Amanda | OTHER | +295,985 | Not reported | 12/01/2028 | 04/16/2026 |
| Boyce Elisabeth Amanda | OTHER | 0 | Not reported | 03/18/2026 | 04/16/2026 |
| Miller Deanne Diem | OTHER | +600,000 | Not reported | 12/01/2028 | 04/13/2026 |
| Voigt Marc | OTHER | +1,200,000 | Not reported | 12/01/2028 | 04/13/2026 |
| Miller Deanne Diem | OTHER | 0 | Not reported | 03/18/2026 | 04/13/2026 |
| Voigt Marc | OTHER | 0 | Not reported | 03/18/2026 | 04/13/2026 |
| Meyers Pete A. | OTHER | +650,000 | Not reported | 12/01/2029 | 04/07/2026 |
| Meyers Pete A. | OTHER | 0 | Not reported | 03/18/2026 | 04/07/2026 |
| Mueller Christian | OTHER | +466,666 | Not reported | 12/01/2028 | 04/01/2026 |
| HOWARD RUSSELL J | OTHER | +461,746 | Not reported | 12/01/2028 | 04/01/2026 |
| Triebel Frederic Joseph Daniel | OTHER | +900,000 | Not reported | 12/01/2028 | 04/01/2026 |
| Winckels Stephan Karel Gerard | OTHER | +221,708 | Not reported | 12/01/2028 | 04/01/2026 |
| Mueller Christian | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| HOWARD RUSSELL J | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Triebel Frederic Joseph Daniel | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Winckels Stephan Karel Gerard | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |